Product Information
GABAPENTIN 400 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.0410 per EA under NDC 62756013904. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
400 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756013904
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA077242On Market Since
2/1/2022
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 400 MG CAPSULE has been published 203 times since Aug 10, 2022, and over the history we have for it it has declined 27.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0410 per EA |
|---|---|
| All-time high | $0.0631 (Nov 16, 2022) |
| All-time low | $0.0396 (Apr 22, 2026) |
| 52-week high | $0.0445 |
| 52-week low | $0.0396 |
| Median price | $0.0515 |
| Average price | $0.0501 |
| Largest weekly change | +23.4% (Aug 21, 2024) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 400 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.0410 per EA (NDC 62756013904), effective Jun 24, 2026.
How has the price of GABAPENTIN 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 400 MG CAPSULE has declined 27.5%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 400 MG CAPSULE?
Since Aug 10, 2022, the NADAC for GABAPENTIN 400 MG CAPSULE has ranged from a low of $0.0396 (Apr 22, 2026) to a high of $0.0631 (Nov 16, 2022), with a median of $0.0515 per EA.
Are there cheaper alternatives to GABAPENTIN 400 MG CAPSULE?
7 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 400 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 400 MG CAPSULE?
GABAPENTIN 400 MG CAPSULE (NDC 62756013904) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification